levofloxacin has been researched along with Erysipelas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Sauer, J; Seifert, A; Weyer, T | 1 |
2 other study(ies) available for levofloxacin and Erysipelas
| Article | Year |
|---|---|
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
[Mitigated erysipelas after implantation of foreign material].
Topics: Aged; Anti-Infective Agents; Arthroplasty, Replacement; Arthroplasty, Replacement, Hip; Disease Progression; Erysipelas; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Osteoarthritis; Osteoarthritis, Hip; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Prosthesis-Related Infections; Reoperation; Shoulder Joint; Topoisomerase II Inhibitors | 2004 |